Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Key Technology of Acupoint Modulation-based Brain Electric Field Therapy for the Treatment of Post-stroke Cognitive Impairment

NCT07208019 is registered in ClinicalTrials.gov with Ruijie Ma as lead sponsor.

NCT NCT07208019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07208019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Key Technology of Acupoint Modulation-based Brain Electric Field Therapy for the Treatment of Post-stroke Cognitive Impairment
Lead sponsor
Ruijie Ma
Phase
Not applicable
Overall status
Recruiting
Start date
October 5, 2025
Completion date
March 30, 2027
Enrollment
340 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

post-stroke cognitive impairment (psci)